J.W. Cole Advisors Inc. Decreases Holdings in SPDR S&P Biotech ETF $XBI

J.W. Cole Advisors Inc. lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 35.5% during the third quarter, HoldingsChannel.com reports. The fund owned 23,580 shares of the exchange traded fund’s stock after selling 12,967 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,363,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Compass Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the third quarter worth about $1,167,000. Prime Capital Investment Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF by 37.9% during the 2nd quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock worth $824,000 after purchasing an additional 2,729 shares in the last quarter. Altfest L J & Co. Inc. increased its stake in shares of SPDR S&P Biotech ETF by 63.1% during the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after purchasing an additional 48,326 shares in the last quarter. Brian Low Financial Group LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $668,000. Finally, AlphaCore Capital LLC lifted its stake in SPDR S&P Biotech ETF by 6,650.0% in the 2nd quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after buying an additional 532 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $125.51 on Friday. The business’s fifty day moving average price is $124.11 and its two-hundred day moving average price is $108.44. The stock has a market cap of $8.39 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $132.09.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.